STOCK TITAN

Senzime Ab (SNZZF) Stock News

SNZZF OTC

Welcome to our dedicated page for Senzime Ab news (Ticker: SNZZF), a resource for investors and traders seeking the latest updates and insights on Senzime Ab stock.

Senzime AB reports recurring developments around its TetraGraph neuromuscular monitoring system, hospital contracting in the United States, and commercialization through integrated delivery networks and group purchasing organizations. Company updates also cover TetraCom connectivity, financial reports, margin and cash-flow commentary, and expansion of U.S. sales, clinical, and medical-affairs functions.

Governance-related announcements include annual general meeting notices and shareholder-program proposals, while operating updates focus on anesthesia data transmission, hospital procurement access, system installations, and recurring revenue tied to the installed base.

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.81%
Tags
none

FAQ

What is the current stock price of Senzime Ab (SNZZF)?

The current stock price of Senzime Ab (SNZZF) is $0.47855 as of June 4, 2026.

What is the market cap of Senzime Ab (SNZZF)?

The market cap of Senzime Ab (SNZZF) is approximately 94.2M.